Susan L. Cohn, MD
Professor of Pediatrics
Dean, Clinical Research
Director, Clinical Research, Section of Pediatric Hematology/Oncology
Susan L. Cohn, MD, is a highly respected expert in pediatric cancers and blood diseases. She is a leading authority on neuroblastoma, a cancer of nerve cells, and the most common type of cancer found in infants.
Dr. Cohn is actively researching several aspects of neuroblastoma. She is one of the few pediatric oncologists in the United States who is conducting Phase I clinical trials of promising treatments for the disease. Her research has received generous support from the National Institutes of Health/National Cancer Institute and the National Institute of Neurological Disorders and Stroke.
In recognition of her extensive expertise in pediatric clinical research, Dr. Cohn was selected to be the first section chief of clinical sciences at the University of Chicago Department of Pediatrics.
Since 1990, Dr. Cohn has held several leadership positions in national pediatric cooperative clinical research groups, including serving as chair of the Children's Oncology Group Neuroblastoma Disease Committee.
A prolific author, Dr. Cohn has published more than 80 peer-reviewed journal articles, several book chapters, and has co-edited two books. She also is a reviewer for many prominent journals, including the New England Journal of Medicine, Cancer Research, and the Journal of Clinical Oncology.
Dr. Cohn has received several awards and honors, and has been selected as a top doctor by Chicago magazine.
The University of Chicago Medicine
Duchossois Center for Advanced Medicine
University of Chicago Specialty Suite at
Year Started Practice
University of Illinois College of Medicine
Michael Reese Hospital and Medical Center, Chicago
Children's Memorial Hospital, Chicago
American Academy of Pediatrics
Office Postal Address
Susan L. Cohn, MD
Request an appointment online
Read More About Dr. Cohn
After being treated for a Wilms tumor in his right kidney, Ryan Bendoff is back to living a normal life. Dr. Cohn says he has greater than a 95 percent chance of a lifelong cure. Read Ryan's story.
Dr. Cohn describes what it is like for a parent to agree to enroll their child in a clinical trial and how this selfless act can impact future children. Read the blog post on Cancer.Net.
When a CT scan detected a mass wrapped around Ellie's spine, the Van Rossums were referred to Dr. Cohn, who diagnosed Ellie with a ganglioneuroblastoma. » Read Ellie's story
When Yano Pournaras was diagnosed with neuroblastoma, his father sought Dr. Cohn's expertise -- and he was willing to travel from South Carolina to get it. » Read Yano's story
Dr. Cohn co-chaired a task force that created recommendations for a global evaluation system for neuroblastoma. The system is designed to enable quicker identification of optimal treatments.
A study led by Dr. Cohn was recently identified by the American Society of Clinical Oncology as among those with the "greatest potential to improve patient care and quality of life." Read the post on University of Chicago Medicine's Cancer Conversation blog to learn more about the study, which focused on the link between ethnic disparities and genetic variation in patients with neuroblastoma.
Dr. Cohn is featured in the University of Chicago Medicine's Science Life blog commenting on a successful clinical trial of a new treatment for neuroblastoma.
View a partial list of Dr. Cohn's publications through the National Library of Medicine's PubMed online database.